PANCREATIC CANCER UK — grant history

Registered charity 1112708 · filings on the Charity Commission register

Latest income

£13.7m

Grants listed (FY2025)

Listed grants total

£2.6m

Accounts grants total

£2.6m

listed grants reconcile with the accounts totalextracted from its FY2025 accounts

Application guidance — from the funder’s own website

Deadlines: Deadline for application is the 6th August 2026

Summarised from www.pancreaticcancer.org.uk · www.pancreaticcancer.org.uk/research/support-for-researchers/funding-opportunities/ · www.pancreaticcancer.org.uk/get-involved/fundraise/ on 16/08/2026. Always check the funder’s site before applying.

What this funder supports

Based on the register classifications and operating areas of the grant recipients we could match to the charity register (a subset of all grantees).

Causes funded

Education/training (1 grantee)
The Advancement Of Health Or Saving Of Lives (1 grantee)

Where grantees operate

Cardiff (1 grantee)

Grants made, per its accounts filings

Download this grant history as CSV (open data, provenance and licence noted in the file).

Recipient	Year	Amount	Purpose
University of Cambridge	FY2025	£330k	Interdisciplinary Treatment Grants - Dr Giulia Biffi & Professor Richard Gilbertson
University of Manchester	FY2025	£329k	Interdisciplinary Treatment Grants - Professor Claus Jørgensen
University of Oxford	FY2025	£312k	Interdisciplinary Treatment Grants - Dr Keaton Jones & Dr Michael Gray
University College London	FY2025	£299k	Collaboration Catalyst Awards - Dr Zainab Rai
University of Cambridge	FY2025	£299k	Collaboration Catalyst Awards - Dr Thomas Yip
University of Cambridge	FY2025	£251k	Collaboration Catalyst Awards - Dr Shalini Rao
Queen Mary University of London	FY2025	£100k	Career Foundation Fellowships - Dr Audrey Lumeau
University of Glasgow	FY2025	£100k	Career Foundation Fellowships - Dr Mathias Tesson
Institute of Cancer Research	FY2025	£100k	Research Innovation Fund Awards - Dr Anguraj Sadanandam
University of Manchester	FY2025	£99k	Research Innovation Fund Awards - Dr Max Nobis
Imperial College London	FY2025	£99k	Research Innovation Fund Awards - Dr Despoina Chrysostomou
The Royal Marsden NHS Foundation Trust	FY2025	£99k	Research Innovation Fund Awards - Dr Katherine Aiken
University of Manchester	FY2025	£94k	Research Innovation Fund Awards - Professor Claus Jørgensen
University of Cambridge	FY2025	£7k	Collaboration Catalyst Awards - Dr Shalini Rao
Imperial College London	FY2025	£7k	Collaboration Catalyst Awards - Dr Patrick Kierkegaard
University of Westminster	FY2025	£7k	Collaboration Catalyst Awards - Dr Pinar Uysal Onganer
University College London	FY2025	£7k	Collaboration Catalyst Awards - Professor Nikolitsa Nomikou
Cardiff University	FY2025	£7k	Collaboration Catalyst Awards - Dr Catherine Hogan
University College London	FY2025	£7k	Collaboration Catalyst Awards - Dr Zainab Rai
Dr Vladimir Teif, University of Essex	FY2024	£500k	Investigating liquid biopsies for the early detection of pancreatic cancer
Prof Nigel Jamieson, University of Glasgow	FY2024	£499k	Improving our understanding of pancreatic cysts to improve the early detection of pancreatic cancer
Dr Shalini V Rao, University of Cambridge	FY2024	£299k	Understanding the causes of tumour growth in early pancreatic cancer
Dr Gianluca Mucciolo, University of Cambridge	FY2024	£260k	Identifying new treatments for advanced pancreatic cancer
Dr Robert Chuter, The Christie NHS Foundation Trust/ University of Manchester	FY2024	£152k	Improving radiotherapy for advanced pancreatic cancer
Prof Nigel Jamieson, University of Glasgow	FY2024	£100k	Understanding resistance to pancreatic cancer treatment
Dr Eui Jung Moon, University of Oxford	FY2024	£100k	Investigating the effect of FLASH radiation on a pancreatic cancer model while protecting normal tissue
Dr Anguraj Sadanandam, The Institute of Cancer Research	FY2024	£100k	Decoding T cell receptor and Developing a vaccine to treat pancreatic neuroendocrine neoplasms
Dr Beatriz Salvador Barbero, Cardiff University	FY2024	£99k	Identifying cells that initiate pancreatic cancer to support early detection
Dr Kofi Oppong, Newcastle upon Tyne Hospitals NHS Trust	FY2024	£99k	Do microbes in the gut and pancreas contribute to the development and outcomes of pancreatic cancer?
Dr Beatriz Salvador Barbero, Cardiff University	FY2024	£99k	Identifying early disease cells as potential biomarkers of early pancreatic cancer (continuation funding)
Prof Pawel Swietach, University of Oxford	FY2024	£99k	Targeting pancreatic cancer cells using pH-sensitive technology
Prof Keith Roberts, University of Birmingham	FY2024	£98k	Detecting pancreatic cancer recurrence after surgery
Dr Leandro Castellano, University of Sussex	FY2024	£97k	Identifying microRNA molecules that regulate pancreatic cancer progression
Dr Christopher McConville, University of Birmingham	FY2024	£87k	Developing an implantable device for localised pancreatic cancer treatment
Imperial College London	FY2023	£652k	Developing a breath test to speed up the detection of pancreatic cancer
University College London	FY2023	£300k	Developing a biobank of samples from people with vague symptoms which may or may not be pancreatic cancer, to support the development of new tools for earlier detection and diagnosis
University College London	FY2023	£300k	Investigating blood proteins and microorganisms to detect pancreatic cancer earlier
The Institute of Cancer Research	FY2023	£300k	Using ultrasound and immunotherapy to treat pancreatic cancer
University of Liverpool	FY2023	£200k	Maintaining the Pancreatic Cancer Risk Register to help improve our understanding of inherited pancreatic cancer risk
Institute of Cancer Research	FY2023	£100k	Uncovering signature molecules to detect treatment resistance in pancreatic cancer
University of Oxford	FY2023	£100k	Using a new type of immune cell to improve pancreatic cancer treatment
Cancer Research UK Beatson Institute	FY2023	£98k	Improving pancreatic cancer therapies
University of Glasgow	FY2023	£98k	Understanding how pancreatic lesions become cancerous to support early diagnosis and timely surgery
Imperial College London	FY2023	£96k	Developing a toolkit to assess GPs’ readiness to use new tests to screen and monitor people at high risk of pancreatic cancer
Dr Mathias Tesson, Beatson Institute, Glasgow	FY2022	£200k	Investigating tumour micro environment diversity to refine precision medicine in genomically unstable pancreatic cancer
Dr Nasir Haider, CRUK Manchester Institute	FY2022	£199k	Investigating therapeutic adaptation of the KRAS gene signalling networks in pancreatic cancer
Dr George Williams, University of Birmingham	FY2022	£190k	Boronic acid smart hydrogels (BASH): reducing the side effects of chemotherapy
Dr Beatriz Salvador Barbero, Cardiff University	FY2022	£183k	Identifying early disease cells as potential biomarkers of early pancreatic cancer
Dr Audrey Lumeau, Barts Cancer Institute, London	FY2022	£176k	Tracking genome evolution in pancreatic cancer
Dr Seth Coffelt, Beatson Institute, Glasgow	FY2022	£125k	Understanding the cooperation between immune and stromal (some connective) cells in secondary pancreatic cancer
Professor Jason Carroll, University of Cambridge	FY2022	£100k	Discovering new drug targets in pancreatic cancer
Professor Eithne Costello, University of Liverpool	FY2022	£100k	Understanding the biology behind pancreatic cancer-associated diabetes
Professor Julia Hippisley-Cox, University of Oxford	FY2022	£100k	Using machine learning to develop a risk tool to predict pancreatic cancer in
Dr Anguraj Sadanandam, Institute of Cancer Research, London	FY2022	£99k	Bioengineering-based targeting of immune cells in pancreatic cancer
Mr Sanjay Pandanaboyana, Freeman Hospital, Newcastle	FY2022	£97k	Assessing the impact on carers of patients with pancreatic cancer
Professor Jen Morton, the Beatson Institute, Glasgow	FY2022	£86k	Investigating how pancreatic cancer cells and other cells in local tumour environment react to radiotherapy
Dr Johan Vande Voorde, Beatson Institute, Glasgow	FY2022	£73k	Investigating whether blocking the breakdown of genetic material prevents the progression of pancreatic cancer
Mr Keith Roberts, University Hospital Birmingham	FY2022	£72k	Developing a metabolomic test to diagnose and quantify insufficient pancreatic digestive enzymes

About this data

This grant list is extracted by automated reading of the grant-maker’s own accounts PDFs as filed with the Charity Commission, and cross-checked against the accounts’ stated grant totals (listed sum 2551915 vs reference 2551966 (0.0% diff; ref=stated)). Recipients are linked to register entries only on an exact charity-number or unambiguous exact-name match. If you represent this funder and want a correction, contact us.